Scilex Holding Co balance sheet
At the end of fiscal 2025, Scilex Holding Co had total assets of $365m, total liabilities of $577m and shareholders' equity of −$208m. It held $5.0m in cash against $106m of debt: net debt of $101m.
Balance sheet
| Fiscal year | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0 | 4 | 2 | 4 | 3 | 5 | 1 |
| Receivables | — | 14 | 21 | 35 | 26 | 15 | 6 |
| Inventory | — | 3 | 1 | 4 | 2 | 5 | 4 |
| Total current assets | 0 | 23 | 30 | 47 | 42 | 38 | 36 |
| Goodwill | — | 13 | 13 | 13 | 13 | 13 | 13 |
| Total assets | 0 | 78 | 87 | 101 | 93 | 365 | 254 |
| Accounts payable | — | 4 | 8 | 41 | 53 | 86 | 121 |
| Total current liabilities | 0 | 169 | 45 | 250 | 260 | 484 | 512 |
| Short-term debt | — | 29 | 0 | 108 | 35 | 83 | 81 |
| Long-term debt | — | 72 | 0 | — | — | — | — |
| Total debt | 0 | 110 | 0 | 125 | 36 | 106 | 81 |
| Total liabilities | 0 | 302 | 50 | 274 | 286 | 577 | 564 |
| Shareholders' equity | 0 | −224 | 36 | −173 | −193 | −208 | −308 |
| Net debt (negative = net cash) | −0 | 106 | −2 | 122 | 32 | 101 | 80 |
| Shares outstanding | 17m | — | — | — | — | — | 7m |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 32 | 26 | 11 | 17 | 12 | 15 | 11 | 6 |
| Inventory | 2 | 2 | 3 | 3 | 1 | 5 | 5 | 4 |
| Total current assets | 40 | 42 | 29 | 34 | 16 | 38 | 42 | 36 |
| Goodwill | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 |
| Total assets | 100 | 93 | 79 | 84 | 276 | 365 | 294 | 254 |
| Accounts payable | 43 | 53 | 57 | 59 | 67 | 86 | 102 | 121 |
| Total current liabilities | 282 | 260 | 276 | 306 | 359 | 484 | 502 | 512 |
| Short-term debt | 85 | 35 | 39 | 40 | 46 | 83 | 81 | 81 |
| Total debt | 85 | 35 | 39 | 40 | 46 | 83 | 81 | 81 |
| Total liabilities | 312 | 286 | 290 | 333 | 456 | 577 | 548 | 564 |
| Shareholders' equity | −211 | −193 | −211 | −249 | −177 | −208 | −249 | −308 |
| Shares outstanding | 132m | 5m | 5m | 5m | 6m | 7m | 8m | 7m |
Compare with peers
- Verrica Pharmaceuticals Inc. balance sheet
- Sunshine Biopharma Inc. balance sheet
- Jaguar Health, Inc. balance sheet
- BGM Group Ltd. balance sheet
- IM Cannabis Corp. balance sheet
Head to head: SCLX vs VRCASBFM vs SCLXJAGX vs SCLX
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies